Zentalis Pharmaceuticals (ZNTL)
(Delayed Data from NSDQ)
$12.54 USD
+0.02 (0.16%)
Updated May 10, 2024 04:00 PM ET
After-Market: $12.55 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -0.85 |
EPS Last Quarter | 0.14 |
Last EPS Surprise | 116.47% |
ABR | 1.40 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.87 |
Next Year | -3.72 |
EPS (TTM) | -3.33 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 40.57M | 24.10M |
# of Estimates | NA | NA | 5 | 1 |
High Estimate | NA | NA | 40.60M | 24.10M |
Low Estimate | NA | NA | 40.56M | 24.10M |
Year ago Sales | 0.00M | 0.00M | NA | 40.57M |
Year over Year Growth Est. | NA | NA | NA | -40.59% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.85 | -0.86 | -2.87 | -3.72 |
# of Estimates | 7 | 6 | 8 | 8 |
Most Recent Consensus | -0.90 | -0.92 | -2.74 | -3.33 |
High Estimate | -0.47 | -0.52 | -1.42 | -2.76 |
Low Estimate | -0.96 | -0.99 | -4.05 | -4.45 |
Year ago EPS | -1.85 | -0.79 | -4.47 | -2.87 |
Year over Year Growth Est. | 54.05% | -8.86% | 35.79% | -29.40% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 5 | 4 | 6 | 4 |
Up Last 30 Days | 5 | 4 | 6 | 4 |
Up Last 60 Days | 5 | 4 | 6 | 4 |
Down Last 7 Days | 1 | 2 | 0 | 2 |
Down Last 30 Days | 1 | 2 | 0 | 2 |
Down Last 60 Days | 1 | 2 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.85 | -0.86 | -2.87 | -3.72 |
7 Days Ago | -0.95 | -0.97 | -3.72 | -3.78 |
30 Days Ago | -0.95 | -0.97 | -3.72 | -3.78 |
60 Days Ago | -0.95 | -0.97 | -3.72 | -3.78 |
90 Days Ago | -0.93 | -0.98 | -3.68 | -3.60 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.85 | -0.86 | -2.58 | -3.63 |
Zacks Consensus Estimate | -0.85 | -0.86 | -2.87 | -3.72 |
Earnings ESP | 0.00% | 0.00% | 10.32% | 2.33% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.14 | -0.83 | -0.79 | -1.85 | NA |
Estimate | -0.85 | -0.92 | -1.01 | -1.06 | NA |
Difference | 0.99 | 0.09 | 0.22 | -0.79 | 0.13 |
Surprise | 116.47% | 9.78% | 21.78% | -74.53% | 18.38% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more